| 2021-03-08 08:05:00 | Nightingale julkistaa suunnitellun listautumisantinsa kiinteän merkintähinnan sekä esitteen liittyen B-sarjan osakkeidensa listaamiseksi Nasdaq First North Growth Market Finland -markkinapaikalle | https://view.news.eu.nasdaq.com/view?id=b1441b5b64ee93f58d209a9bbaf339b5c&lang=fi&src=listed |
| 2021-03-08 08:05:00 | Nightingale has applied for its series B shares to be listed on Nasdaq First North Growth Market Finland and commences the initial public offering | https://view.news.eu.nasdaq.com/view?id=bb4b797dfbdffd5059a54eecb94354fb4&lang=en&src=listed |
| 2021-03-08 08:05:00 | Nightingale announces a fixed subscription price and publishes a prospectus for its contemplated IPO and listing of its series B shares on Nasdaq First North Growth Market Finland | https://view.news.eu.nasdaq.com/view?id=b8c3b653ddaa28bd590998c1e8dec5811&lang=en&src=listed |
| 2021-03-08 08:05:00 | Nightingale on hakenut B-sarjan osakkeidensa listaamista Nasdaq First North Growth Market Finland -markkinapaikalle ja aloittaa listautumisannin | https://view.news.eu.nasdaq.com/view?id=b495f60b9ef98821c459dea3d856c0136&lang=fi&src=listed |
| 2021-03-15 18:00:00 | Nightingale Health Oyj kommentoi uutisointia listautumisannistaan | https://view.news.eu.nasdaq.com/view?id=b9d69e65526d781f67359154148076fe9&lang=fi&src=listed |
| 2021-03-15 18:00:00 | Nightingale Health Plc comments on the media coverage on its initial public offering | https://view.news.eu.nasdaq.com/view?id=ba73e4e282aa16442f7132d279840dae2&lang=en&src=listed |
| 2021-03-16 17:00:00 | Public offering of Nightingale has been oversubscribed and therefore the subscription period has been discontinued | https://view.news.eu.nasdaq.com/view?id=b8659301bde201528a3abaa8ce0324bd6&lang=en&src=listed |
| 2021-03-16 17:00:00 | Nightingalen yleisöanti on ylimerkitty minkä vuoksi merkintäaika on keskeytetty | https://view.news.eu.nasdaq.com/view?id=bb15d2d9f115b543bacc2611835b55ca0&lang=fi&src=listed |
| 2021-03-18 18:02:28 | Nightingalen listautumisanti on ylimerkitty ja listautuminen toteutetaan suunnitellusti – B-sarjan osakkeiden kaupankäynnin odotetaan alkavan 19.3.2021 | https://view.news.eu.nasdaq.com/view?id=bf154b20f9cc1120d13bcd5df2a5384d6&lang=fi&src=listed |
| 2021-03-18 18:02:28 | The IPO of Nightingale has been oversubscribed and the listing will be completed as planned – trading in the series B shares is expected to commence on 19 March 2021 | https://view.news.eu.nasdaq.com/view?id=b7eb09e14e64a62df27339fe5ac41c9a2&lang=en&src=listed |
| 2021-03-23 08:30:00 | Nightingale Health Oyj – Johdon liiketoimet – Timo Soininen | https://view.news.eu.nasdaq.com/view?id=bf081dcc5107d89c576396978cf03e87a&lang=fi&src=listed |
| 2021-03-23 08:30:00 | Nightingale Health Plc – Managers’ transactions – Teemu Suna | https://view.news.eu.nasdaq.com/view?id=b965a5d00adb660a4c49d2c45a93c6894&lang=en&src=listed |
| 2021-03-23 08:30:00 | Nightingale Health Oyj – Johdon liiketoimet – Leena Niemistö | https://view.news.eu.nasdaq.com/view?id=b02c6bb615ebefc1e2bd4b8cef4452304&lang=fi&src=listed |
| 2021-03-23 08:30:00 | Nightingale Health Plc – Managers’ transactions – Kari Niemistö | https://view.news.eu.nasdaq.com/view?id=b8a888b133a6ad75f66bd0e41e9a374f9&lang=en&src=listed |
| 2021-03-23 08:30:00 | Nightingale Health Oyj – Johdon liiketoimet – Teemu Suna | https://view.news.eu.nasdaq.com/view?id=b2f12ede8093643325a644c21cfc80789&lang=fi&src=listed |
| 2021-03-23 08:30:00 | Nightingale Health Plc – Managers’ transactions – Leena Niemistö | https://view.news.eu.nasdaq.com/view?id=b50552e71c2160b028d0e1ae06e3494d0&lang=en&src=listed |
| 2021-03-23 08:30:00 | Nightingale Health Oyj – Johdon liiketoimet – Kari Niemistö | https://view.news.eu.nasdaq.com/view?id=bba377cf9690a9e61e85f76a65b8fc66d&lang=fi&src=listed |
| 2021-03-23 08:30:00 | Nightingale Health Plc – Managers’ transactions – Timo Soininen | https://view.news.eu.nasdaq.com/view?id=ba47f80ea8ddab7da49d9e0537306309c&lang=en&src=listed |
| 2021-03-23 08:50:00 | Vakauttamistoimenpiteitä suoritettu ja vakauttamisaika päättynyt; hallitus on päättänyt omien osakkeiden mitätöinnistä | https://view.news.eu.nasdaq.com/view?id=b15d002c673c03e47adc13f780301b419&lang=fi&src=listed |
| 2021-03-23 08:50:00 | Stabilisation measures taken and the end of the stabilisation period; the Board of Directors has resolved on the cancellation of treasury shares | https://view.news.eu.nasdaq.com/view?id=b987ef289e721df53a56a90b9ce72c22f&lang=en&src=listed |
| 2021-03-24 08:30:00 | Nightingale Health Oyj – Johdon liiketoimet – Timo Soininen | https://view.news.eu.nasdaq.com/view?id=be67437146e45d06a91fb4ac65a8e1f4a&lang=fi&src=listed |
| 2021-03-24 08:30:00 | Nightingale Health Plc – Managers’ transactions – Timo Soininen | https://view.news.eu.nasdaq.com/view?id=bb9ba6984ac23f2bd3cb595e1b66e3def&lang=en&src=listed |
| 2021-03-25 08:30:00 | Nightingale Health Plc – Managers’ transactions – Timo Soininen | https://view.news.eu.nasdaq.com/view?id=bb83a268d9f66722148c1f0a6d331db81&lang=en&src=listed |
| 2021-03-25 08:30:00 | Nightingale Health Oyj – Johdon liiketoimet – Timo Soininen | https://view.news.eu.nasdaq.com/view?id=b26ab62769226fc2b5eae877e87d36eb1&lang=fi&src=listed |
| 2021-03-25 20:01:27 | Nightingale Health Plc’s ten largest shareholders after the completion of the initial public offering | https://view.news.eu.nasdaq.com/view?id=bbdd04a0607a2ebbca72a9f392b8cdc38&lang=en&src=listed |
| 2021-03-25 20:01:27 | Nightingale Health Oyj:n kymmenen suurinta osakkeenomistajaa listautumisannin päättymisen jälkeen | https://view.news.eu.nasdaq.com/view?id=bf3a588c1d5ccd76b743aac3324659b22&lang=fi&src=listed |
| 2021-03-30 08:30:00 | Nightingale Health Plc – Managers’ transactions – Timo Soininen | https://view.news.eu.nasdaq.com/view?id=b1c4c3d9d3d016f6ea3071d24d85948b0&lang=en&src=listed |
| 2021-03-30 08:30:00 | Nightingale Health Oyj – Johdon liiketoimet – Timo Soininen | https://view.news.eu.nasdaq.com/view?id=b9fa6c4e7c836b1edecde565bb61f5c7d&lang=fi&src=listed |
| 2021-03-31 13:00:00 | The cancellation of Nightingale Health Plc’s treasury shares entered in the Trade Register | https://view.news.eu.nasdaq.com/view?id=b2b00e5df329f98d0f8059ce8ecac4482&lang=en&src=listed |
| 2021-03-31 13:00:00 | Nightingale Health Oyj:n omien osakkeiden mitätöinti merkitty kaupparekisteriin | https://view.news.eu.nasdaq.com/view?id=b5a128b9d0a41a74e0aba0d400238763a&lang=fi&src=listed |
| 2021-04-07 08:30:00 | Nightingale Health Oyj – Johdon liiketoimet – Timo Soininen | https://view.news.eu.nasdaq.com/view?id=bb9db0b80f5e23f4d98606a4985a77bee&lang=fi&src=listed |
| 2021-04-07 08:30:00 | Nightingale Health Plc – Managers’ transactions – Timo Soininen | https://view.news.eu.nasdaq.com/view?id=beacc4b7c52147f7d3545535828f709dc&lang=en&src=listed |
| 2021-04-09 11:11:25 | Nightingale Health Oyj:n tytäryhtiölle myönnettiin kliinisen laboratorion sertifiointi Japanissa | https://view.news.eu.nasdaq.com/view?id=bd5c955c8fed02a97f5ab0fe3f2de3ea2&lang=fi&src=listed |
| 2021-04-09 11:11:25 | Nightingale Health Plc’s subsidiary received clinical laboratory certification in Japan | https://view.news.eu.nasdaq.com/view?id=b9d8047b95a0304b19db9959f36283e83&lang=en&src=listed |
| 2021-04-22 09:00:00 | Nightingale Health Oyj on solminut strategisen yhteistyösopimuksen Terveystalon kanssa | https://view.news.eu.nasdaq.com/view?id=b08d057d55e39875f3e871577a67c2a63&lang=fi&src=listed |
| 2021-04-22 09:00:00 | Nightingale Health Plc and Terveystalo have entered into strategic partnership agreement | https://view.news.eu.nasdaq.com/view?id=b54832fae547b93d7ed0cadea4a685c02&lang=en&src=listed |
| 2021-04-29 08:15:00 | Nightingale Health signed service agreement for health and well-being services in Japan | https://view.news.eu.nasdaq.com/view?id=b7d18c313f9e4488aa355203cf1b0e73a&lang=en&src=listed |
| 2021-04-29 08:15:00 | Nightingale Health on solminut terveys- ja hyvinvointipalveluiden myyntiä koskevan sopimuksen Japanissa | https://view.news.eu.nasdaq.com/view?id=bd293dd62591c28907f066b4db7d987fb&lang=fi&src=listed |
| 2021-05-04 08:30:00 | Nightingale uudelleen organisoi johtoryhmäänsä ja perustaa strategisen kumppanuuden Reaktorin kanssa | https://view.news.eu.nasdaq.com/view?id=b07e6d3d40d21966be4c5769d88ad8392&lang=fi&src=listed |
| 2021-05-04 08:30:00 | Nightingale restructures its Management Team and establishes strategic partnership with Reaktor | https://view.news.eu.nasdaq.com/view?id=b76091282cd7ba958ed8b0b5215ed6ace&lang=en&src=listed |
| 2021-06-23 08:30:00 | Nightingale successfully completes the first phase of its at-home blood testing pilot | https://view.news.eu.nasdaq.com/view?id=b9b3300fc17027f8f6ad1ded904b4c2a6&lang=en&src=listed |
| 2021-06-23 08:30:00 | Nightingale on saattanut onnistuneesti päätökseen kotitestipilotin ensimmäisen vaiheen | https://view.news.eu.nasdaq.com/view?id=b0f630950f7a8e91e05d4784b8f78b6a7&lang=fi&src=listed |
| 2021-06-29 08:40:00 | Nightingale secures global scalability of its at-home solution by partnering with at-home blood collection device manufacturer Weavr with new commercial terms and minority investment | https://view.news.eu.nasdaq.com/view?id=b905ec155c927ca69fdb3936a545d0062&lang=en&src=listed |
| 2021-06-29 08:40:00 | Nightingale on varmistanut kotitestinsä kansainvälisen skaalautuvuuden kumppanoitumalla verenkeräyslaitevalmistaja Weavrin kanssa uudistamalla kaupalliset ehdot sekä tekemällä vähemmistösijoituksen | https://view.news.eu.nasdaq.com/view?id=b5e0b866ba6f1163abf3efb075bc74508&lang=fi&src=listed |
| 2021-07-01 08:25:00 | Nightingale Healthin yhteenveto vuosineljänneksen aikana saavutetuista keskeisistä tavoitteista sekä kertaus lyhyen aikavälin liiketoiminnan tavoitteista | https://view.news.eu.nasdaq.com/view?id=bf67379aa1535bb5c5c227077a57040bd&lang=fi&src=listed |
| 2021-07-01 08:25:00 | Nightingale Health quarterly summary of achieved key milestones and reiteration of near-term business targets | https://view.news.eu.nasdaq.com/view?id=bfb441ce67040e8f4baf541fcd2db0f09&lang=en&src=listed |
| 2021-07-09 08:40:00 | Nightingale Health acquires German digital health company Yolife GmbH | https://view.news.eu.nasdaq.com/view?id=bd0d9756bceab7bc59eec8d563e5837df&lang=en&src=listed |
| 2021-07-09 08:40:00 | Nightingale Health ostaa saksalaisen digitaalisiin terveysratkaisuihin erikoistuneen Yolife GmbH:n | https://view.news.eu.nasdaq.com/view?id=b60c4b8d5354ad2cf9ab502bbe43a6bec&lang=fi&src=listed |
| 2021-08-30 08:00:00 | Jeffrey Barrett appointed as Chief Scientific Officer of Nightingale Health Plc | https://view.news.eu.nasdaq.com/view?id=be4a4c7fed652fa951316379b324bea6f&lang=en&src=listed |
| 2021-08-30 08:00:00 | Jeffrey Barrett nimitetty Nightingale Health Oyj:n tieteelliseksi johtajaksi | https://view.news.eu.nasdaq.com/view?id=bc59bc0a1b67b44256afb69b40f95dbe2&lang=fi&src=listed |
| 2021-09-07 11:30:00 | Nightingale to publish Financial Statements Release for financial year July 2020–June 2021 on 15 September 2021 | https://view.news.eu.nasdaq.com/view?id=b8918ce8db81e66c21329769c21865346&lang=en&src=listed |
| 2021-09-15 08:00:00 | Nightingale Health Plc Financial Statements Release 1 July 2020 – 30 June 2021 | https://view.news.eu.nasdaq.com/view?id=ba39543087a877bc2c6f9e23a27d7f841&lang=en&src=listed |
| 2021-09-15 08:00:00 | Nightingale Health Oyj tilinpäätöstiedote 1.7.2020–30.6.2021 | https://view.news.eu.nasdaq.com/view?id=bcc173d5e5a25731eb3900371c13e6e4f&lang=fi&src=listed |
| 2021-10-01 10:30:00 | Nightingalen vuosikertomus tilikaudelta 2020–2021 on julkaistu | https://view.news.eu.nasdaq.com/view?id=bde6799656746311c4fc73e8fc2592cc6&lang=fi&src=listed |
| 2021-10-01 10:30:00 | Nightingale’s Annual Report for financial year 2020–2021 published | https://view.news.eu.nasdaq.com/view?id=b049cda459f674fed5d1834810f9ea9fb&lang=en&src=listed |
| 2021-10-01 12:30:00 | Notice to the Annual General Meeting of Nightingale Health Plc | https://view.news.eu.nasdaq.com/view?id=bc56e646ad90177dae3184e05f1789d8d&lang=en&src=listed |
| 2021-10-01 12:30:00 | Kutsu Nightingale Health Oyj:n varsinaiseen yhtiökokoukseen | https://view.news.eu.nasdaq.com/view?id=bd7d69f0589e07de4389d4f73349ba888&lang=fi&src=listed |
| 2021-10-07 08:30:00 | Nightingale on saanut CE merkinnän kotitestauspakkaukselleen | https://view.news.eu.nasdaq.com/view?id=bf7140c0bca4abc2eda45ceb2174174da&lang=fi&src=listed |
| 2021-10-07 08:30:00 | Nightingale receives CE marking for its at-home blood collection kit | https://view.news.eu.nasdaq.com/view?id=bab2ebbb7df6a3bb258ab40ed1b01d3fa&lang=en&src=listed |
| 2021-10-13 06:50:00 | Nightingale ja Terveystalo lanseeraavat uuden hyvinvointijäsenyyden | https://view.news.eu.nasdaq.com/view?id=b2c5fe6939e0e0c967e19d56b01801dc4&lang=fi&src=listed |
| 2021-10-13 06:50:00 | Nightingale and Terveystalo launch a new well-being membership | https://view.news.eu.nasdaq.com/view?id=bfe5a78f7d5523061b33f4c6dfc76b622&lang=en&src=listed |
| 2021-10-14 08:50:00 | Fimea inspected Nightingale’s regulatory compliance with the requirements for manufacturer of medical device | https://view.news.eu.nasdaq.com/view?id=be492d2a595f283ac37c154dce56f6193&lang=en&src=listed |
| 2021-10-14 08:50:00 | Fimea on tarkastanut Nightingalen täyttävän lääkinnällisen laitteen valmistajan vaatimustenmukaisuuden | https://view.news.eu.nasdaq.com/view?id=b78fac4e8dcf988f0d9b5415408ae955d&lang=fi&src=listed |
| 2021-10-18 14:00:00 | Kutsu tapahtumaan: An hour with Nightingale | https://view.news.eu.nasdaq.com/view?id=b0865a76e933ef8e0228d5beb284b7fe0&lang=fi&src=listed |
| 2021-10-18 14:00:00 | Invitation to event: An hour with Nightingale | https://view.news.eu.nasdaq.com/view?id=b0e485127a90571447e850e7732c92d75&lang=en&src=listed |
| 2021-10-27 08:00:00 | Nightingale and major Finnish pharmacy chain Yliopiston Apteekki enter into nation-wide distribution partnership of Nightingale’s at-home testing solution | https://view.news.eu.nasdaq.com/view?id=b2193881fd8373ca392fdfdf18a97545a&lang=en&src=listed |
| 2021-10-27 08:00:00 | Nightingale ja merkittävä suomalainen apteekkiketju Yliopiston Apteekki yhteistyöhön aloittaakseen Nightingalen kotitestiratkaisun maanlaajuisen jakelun | https://view.news.eu.nasdaq.com/view?id=bc3e3076eaaa9a5123e7b2cb9c15d9b8b&lang=fi&src=listed |
| 2021-10-28 08:00:00 | Nightingale ja BioBank Japan julkistavat yhteistyön yksilöllisen lääketieteen ja ennaltaehkäisevän terveyden toteuttamiseksi Japanissa | https://view.news.eu.nasdaq.com/view?id=b1188032bb61159bfd80c7d0555313716&lang=fi&src=listed |
| 2021-10-28 08:00:00 | Nightingale and BioBank Japan to realise personalised medicine and preventative health in Japan | https://view.news.eu.nasdaq.com/view?id=b1ab16aa641eb55d85a19a8bd2785d52c&lang=en&src=listed |
| 2021-10-28 14:00:00 | Tallenne tapahtumasta: An hour with Nightingale | https://view.news.eu.nasdaq.com/view?id=bbca75bdfab3b16724ce15d8cec36e506&lang=fi&src=listed |
| 2021-10-28 14:00:00 | Recording of event: An hour with Nightingale | https://view.news.eu.nasdaq.com/view?id=b70c5860166880e3631017b6e0da64d8a&lang=en&src=listed |
| 2021-10-28 17:15:00 | Resolutions of Nightingale Health Plc’s Annual General Meeting and Board of Directors | https://view.news.eu.nasdaq.com/view?id=b1e90df926367e39c31e367326d083328&lang=en&src=listed |
| 2021-10-28 17:15:00 | Nightingale Health Oyj:n varsinaisen yhtiökokouksen ja hallituksen päätökset | https://view.news.eu.nasdaq.com/view?id=b0cb505a47ca79fdd24fdcce0d96ef8b5&lang=fi&src=listed |
| 2021-10-29 14:00:00 | Conversion of Nightingale Health Plc’s Series A shares and EMP shares to Series B shares | https://view.news.eu.nasdaq.com/view?id=b122f5da417d9bc724f7417c43a4a924d&lang=en&src=listed |
| 2021-10-29 14:00:00 | Nightingale Health Oyj:n A-sarjan osakkeiden ja EMP-osakkeiden muunto B-sarjan osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bf71509e12a1dcd216748e09cb7999051&lang=fi&src=listed |
| 2021-11-02 08:00:00 | Tuukka Paavola appointed as Chief Financial Officer of Nightingale Health Plc | https://view.news.eu.nasdaq.com/view?id=bcbcf2cd0d722eec2525ac7365ea742db&lang=en&src=listed |
| 2021-11-02 08:00:00 | Tuukka Paavola nimitetty Nightingale Health Oyj:n talousjohtajaksi | https://view.news.eu.nasdaq.com/view?id=b0c07b53598fc3dbdf9a503085d47673d&lang=fi&src=listed |
| 2021-11-15 08:00:00 | Nightingale launches Nightingale Home and Nightingale Pro service models | https://view.news.eu.nasdaq.com/view?id=b0768c9e8702ffec296dc00f00fa943d1&lang=en&src=listed |
| 2021-11-15 08:00:00 | Nightingale lanseeraa Nightingale Home - ja Nightingale Pro -palvelumallit | https://view.news.eu.nasdaq.com/view?id=bdc6c5f061b68337dad2c8dd545d73fbf&lang=fi&src=listed |
| 2021-11-18 08:00:00 | Nightingale’s corporate health service piloted at Mitsui headquarters in Tokyo | https://view.news.eu.nasdaq.com/view?id=bf3a9d4c422d92eb59fd130b213d0b034&lang=en&src=listed |
| 2021-11-18 08:00:00 | Nightingalen työhyvinvointipalvelua pilotoidaan Mitsuin pääkonttorilla Japanissa | https://view.news.eu.nasdaq.com/view?id=b56f04bd52aaa0860cd0ea780de1c4cdd&lang=fi&src=listed |
| 2021-12-17 08:00:00 | Nightingale laajentaa Japanin laboratoriotaan | https://view.news.eu.nasdaq.com/view?id=b6572b45c7f4a92ca7cd09adfc2c9c3df&lang=fi&src=listed |
| 2021-12-17 08:00:00 | Nightingale expands its Japan laboratory | https://view.news.eu.nasdaq.com/view?id=b62427dd86418fe84f16be0ec8e8f3375&lang=en&src=listed |
| 2021-12-21 08:00:00 | Nightingale’s preventative health service launched at Shin-Oyama City Hospital in Japan | https://view.news.eu.nasdaq.com/view?id=b1509deedd88ab3560486aedebf644583&lang=en&src=listed |
| 2021-12-21 08:00:00 | Nightingalen ennaltaehkäisevä terveyspalvelu lanseerattu Shin-Oyama City sairaalassa Japanissa | https://view.news.eu.nasdaq.com/view?id=bc8097cf85886db7dd52c393082f1807b&lang=fi&src=listed |
| 2021-12-22 08:50:00 | Nightingale Home -palvelu lanseerattu merkittävän suomalaisen apteekkiketjun Yliopiston Apteekin kanssa | https://view.news.eu.nasdaq.com/view?id=bf9119c7fc5e5aa131b8bcc33af85587a&lang=fi&src=listed |
| 2021-12-22 08:50:00 | Nightingale Home service launched with major Finnish pharmacy chain Yliopiston Apteekki | https://view.news.eu.nasdaq.com/view?id=b7ef0fd44a5fa6fe3110d2262c7268dec&lang=en&src=listed |
| 2022-01-18 08:20:00 | Nightingale introduces combination of its proprietary blood test and genomics: acquires Finnish genetic testing company Negen and launches international centre of excellence for genomic data analysis | https://view.news.eu.nasdaq.com/view?id=beb52597e96c7d717c61c4a47f7000967&lang=en&src=listed |
| 2022-01-18 08:20:00 | Nightingale yhdistää genetiikan kehittämäänsä verianalyysiin – laajentuminen toteutetaan hankkimalla suomalainen genetiikka-alan yritys Negen sekä perustamalla genetiikan huippuyksikkö | https://view.news.eu.nasdaq.com/view?id=bb341e0ad6d07c41ceb728db0755d9d55&lang=fi&src=listed |
| 2022-01-20 08:15:00 | Nightingalen tietoturvallisuuden hallintajärjestelmän sertifikaattia jatkettu poikkeuksellisen hyvin tuloksin seuranta-auditoinnissa | https://view.news.eu.nasdaq.com/view?id=b96a6adb830dfd3299008d670025bb9e2&lang=fi&src=listed |
| 2022-01-20 08:15:00 | Nightingale’s information security management certification continued with outstanding results in surveillance audit | https://view.news.eu.nasdaq.com/view?id=bedff6fd80c84837dfb3988b03b578c4f&lang=en&src=listed |
| 2022-02-03 08:15:00 | Nightingale has completed the acquisition of Finnish genetic testing company Negen | https://view.news.eu.nasdaq.com/view?id=bcbbf3d3c1e4f12330017a27b44f3378b&lang=en&src=listed |
| 2022-02-03 08:15:00 | Nightingale on saattanut päätökseen suomalaisen genetiikka-alan yrityksen Negenin yrityskaupan | https://view.news.eu.nasdaq.com/view?id=b4df6d86b742b83880cc6c7c21f9d1587&lang=fi&src=listed |
| 2022-02-08 15:00:00 | Conversion of Nightingale Health Plc’s Series A shares to Series B shares | https://view.news.eu.nasdaq.com/view?id=b88d30b51b2c6963c7a73f82c40509c11&lang=en&src=listed |
| 2022-02-08 15:00:00 | Nightingale Health Oyj:n A-sarjan osakkeiden muunto B-sarjan osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b2b36628e9b0ef4cfc224ea7fc0173481&lang=fi&src=listed |
| 2022-02-16 11:00:00 | Nightingale julkaisee 24.2.2022 puolivuotiskatsauksen heinä–joulukuulta 2021 | https://view.news.eu.nasdaq.com/view?id=b55c279b798ac17398acb5a0cf4389e3a&lang=fi&src=listed |
| 2022-02-16 11:00:00 | Nightingale to publish half-year report for July – December 2021 on 24 February 2022 | https://view.news.eu.nasdaq.com/view?id=b8bd3cbb94bf6b88a2373876be3858686&lang=en&src=listed |
| 2022-02-24 08:00:00 | Nightingale Health Group’s Half-year report 1 July 2021 – 31 December 2021: Progressing faster than expected in line with strategy | https://view.news.eu.nasdaq.com/view?id=b894f653580796498678c48c83157e6f8&lang=en&src=listed |
| 2022-02-24 08:00:00 | Nightingale Health -konsernin puolivuotiskatsaus 1.7.2021–31.12.2021: Odotettua nopeampaa etenemistä strategian mukaisesti | https://view.news.eu.nasdaq.com/view?id=b41f6c6c239eef2d4f36e63d413c69241&lang=fi&src=listed |
| 2022-03-18 08:45:00 | Nightingale’s Board of Directors resolved on new share-based incentive plans | https://view.news.eu.nasdaq.com/view?id=b4de6faa5603965d7936727038b298308&lang=en&src=listed |
| 2022-03-18 08:45:00 | Nightingalen hallitus on päättänyt uusista osakepohjaisista kannustinohjelmista | https://view.news.eu.nasdaq.com/view?id=b26b794a31007dfa629a99544735669b9&lang=fi&src=listed |
| 2022-03-31 08:00:00 | Nightingale Health lanseeraa kotitestiratkaisuaan hyödyntävän kuluttajapalvelun Livit by Nightingale Health | https://view.news.eu.nasdaq.com/view?id=b1b504a260c8e231e771bcd82b0f855ef&lang=fi&src=listed |
| 2022-03-31 08:00:00 | Nightingale Health launches consumer service Livit by Nightingale Health utilizing its at-home testing solution | https://view.news.eu.nasdaq.com/view?id=b61470d8821cae4b76cc2b24db34625e6&lang=en&src=listed |
| 2022-05-19 16:35:00 | Conversion of Nightingale Health Plc's Series A shares and EMP shares to Series B shares | https://view.news.eu.nasdaq.com/view?id=b78017072c2cdbe11e2bafa46d0afdfa9&lang=en&src=listed |
| 2022-05-19 16:35:00 | Nightingale Health Oyj:n A-sarjan osakkeiden ja EMP-osakkeiden muunto B-sarjan osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b8b14298dac4bf66089f327ffa247c219&lang=fi&src=listed |
| 2022-05-31 08:30:00 | Analysis: Nightingale Health's net impact among the top 7% of companies worldwide | https://view.news.eu.nasdaq.com/view?id=b2ae5b05853d805cf878de1b8adf8dbac&lang=en&src=listed |
| 2022-05-31 08:30:00 | Analyysi: Nightingale Health sijoittuu nettovaikutuksiltaan globaalisti parhaaseen seitsemään prosenttiin | https://view.news.eu.nasdaq.com/view?id=bea9e2ddee7f1cb1792956d0aac7ec503&lang=fi&src=listed |
| 2022-06-08 09:15:00 | Nightingale Health sopii kumppanuudesta Physitrackin kanssa laajentaen Livit-hyvinvointipalvelun saatavuutta Saksaan ja Iso-Britanniaan sekä Pohjoismaissa | https://view.news.eu.nasdaq.com/view?id=b9bc02c736f7d2701afd5ab4699586b65&lang=fi&src=listed |
| 2022-06-08 09:15:00 | Nightingale Health partners with Physitrack expanding the availability of its preventative wellbeing service Livit to Germany the UK and in the Nordics | https://view.news.eu.nasdaq.com/view?id=bfc8e617fb7bb599ca6d9a84f0b1bfce5&lang=en&src=listed |
| 2022-06-08 16:05:00 | Notice to the Extraordinary General Meeting of Nightingale Health Plc | https://view.news.eu.nasdaq.com/view?id=bbdf63ba4a7b909179eaf6215ea8a7c37&lang=en&src=listed |
| 2022-06-08 16:05:00 | Kutsu Nightingale Health Oyj:n ylimääräiseen yhtiökokoukseen | https://view.news.eu.nasdaq.com/view?id=ba327f519feb69d83eb10c4d41b5adf8a&lang=fi&src=listed |
| 2022-06-14 08:20:00 | Nightingale Healthin teknologian sairastumisriskien tunnistamiskyvylle lisää tieteellistä näyttöä satojen sairauksien osalta | https://view.news.eu.nasdaq.com/view?id=bc420d9b505a0026816ee5489eec8be52&lang=fi&src=listed |
| 2022-06-14 08:20:00 | Further landmark evidence released to showcase the ability of Nightingale Health's technology to predict hundreds of diseases from a single blood sample | https://view.news.eu.nasdaq.com/view?id=b4df43a05d40d968d6e94419849a064fa&lang=en&src=listed |
| 2022-06-15 08:00:00 | Nightingale Health Oyj:n taloudellinen tiedottaminen ja varsinainen yhtiökokous tilikaudella 2022-2023 | https://view.news.eu.nasdaq.com/view?id=b7e329c97221e233aebaaaa11cb1ea532&lang=fi&src=listed |
| 2022-06-15 08:00:00 | Nightingale Health Plc's financial reporting and Annual General Meeting in financial year 2022 - 2023 | https://view.news.eu.nasdaq.com/view?id=bf2599079273bc9f831dfa4d16be986b5&lang=en&src=listed |
| 2022-06-29 15:45:00 | Nightingale Health Oyj:n ylimääräisen yhtiökokouksen päätökset | https://view.news.eu.nasdaq.com/view?id=bdda634d56412f13dfcd15952f228208b&lang=fi&src=listed |
| 2022-06-29 15:45:00 | Resolutions of Nightingale Health Plc's Extraordinary General Meeting | https://view.news.eu.nasdaq.com/view?id=b8315d957194b6c35cc09ad88d4837b9c&lang=en&src=listed |
| 2022-07-05 07:30:00 | Päivitys Nightingale Health Oyj:n tilikaudelle 2021-2022 asetetuista liiketoimintatavoitteista | https://view.news.eu.nasdaq.com/view?id=bcc08e2ba7d22baa42b49d88e9961058f&lang=fi&src=listed |
| 2022-07-05 07:30:00 | Update on Nightingale Health Plc's business targets for financial year 2021 - 2022 | https://view.news.eu.nasdaq.com/view?id=b4856cd1f265942bc1d77bb60736c3286&lang=en&src=listed |
| 2022-08-11 08:30:00 | Nightingale Health's Board of Directors resolved on a change to the share-based incentive schemes | https://view.news.eu.nasdaq.com/view?id=bf16ec4735559cdf0a75f4dbd2c030c99&lang=en&src=listed |
| 2022-08-11 08:30:00 | Nightingale Healthin hallitus on päättänyt muutoksesta osakepohjaisiin kannustinohjelmiin | https://view.news.eu.nasdaq.com/view?id=b94bc931add9a014e58e249e73ab2d2b6&lang=fi&src=listed |
| 2022-09-23 14:45:00 | Nightingale Health julkaisee 29.9.2022 tilinpäätöstiedotteen kaudelta heinäkuu 2021-kesäkuu 2022 | https://view.news.eu.nasdaq.com/view?id=b48092f180bf06197afb76a938a64d4cf&lang=fi&src=listed |
| 2022-09-23 14:45:00 | Nightingale Health to publish Financial Statements Release for financial year July 2021-June 2022 on 29 September 2022 | https://view.news.eu.nasdaq.com/view?id=be4281dd54988eab6ff1fb107019b3a9e&lang=en&src=listed |
| 2022-09-29 08:00:00 | Nightingale Health Oyj tilinpäätöstiedote 1.7.2021-30.6.2022 | https://view.news.eu.nasdaq.com/view?id=b1139c4ff9bc60f0c2c0d3cbc6baf1e1d&lang=fi&src=listed |
| 2022-09-29 08:00:00 | Nightingale Health Plc Financial Statements Release 1 July 2021-30 June 2022 | https://view.news.eu.nasdaq.com/view?id=ba581d462a01db8bf59c31529de89e6cd&lang=en&src=listed |
| 2022-10-07 08:00:00 | Independent study: Nightingale Health's blood test shown to enhance health check-ups by predicting many diseases at once | https://view.news.eu.nasdaq.com/view?id=b5417b56b0e30f916a8add0ee7d734347&lang=en&src=listed |
| 2022-10-07 08:00:00 | Riippumaton tutkimus: Nightingale Healthin verianalyysi tehostaa terveystarkastuksia ennustamalla kerralla monta sairautta | https://view.news.eu.nasdaq.com/view?id=b0000a82fc81166eb303801157fef125a&lang=fi&src=listed |
| 2022-10-14 08:15:00 | Kutsu Nightingale Health Oyj:n varsinaiseen yhtiökokoukseen | https://view.news.eu.nasdaq.com/view?id=be42aff26425a94989abd48169c9e8bd7&lang=fi&src=listed |
| 2022-10-14 08:15:00 | Notice to the Annual General Meeting of Nightingale Health Plc | https://view.news.eu.nasdaq.com/view?id=bc3e4df380f0b89d32cb029e9cfc5516a&lang=en&src=listed |
| 2022-10-27 08:00:00 | Nightingale Health Oyj: Kansainvälisten tilinpäätösstandardien (IFRS) käyttöönotto ja tilintarkastamattomat taloudelliset tiedot vertailukaudelta | https://view.news.eu.nasdaq.com/view?id=ba5050b189a337bb6c437490676a82be1&lang=fi&src=listed |
| 2022-10-27 08:00:00 | Nightingale Health Plc: Adoption of International Financial Reporting Standards (IFRS) and unaudited financial information for the comparative period | https://view.news.eu.nasdaq.com/view?id=b08e3ec2691b702b6f89a70d6cd05cdbe&lang=en&src=listed |
| 2022-10-27 22:25:00 | Nightingale Health's Annual Report for financial year 2021-2022 has been published | https://view.news.eu.nasdaq.com/view?id=b164757cdf3f386d5d293922593e0dd99&lang=en&src=listed |
| 2022-10-27 22:25:00 | Nightingale Healthin vuosikertomus tilikaudelta 2021-2022 on julkaistu | https://view.news.eu.nasdaq.com/view?id=b946c26afd9a38234be1bbe342b80c783&lang=fi&src=listed |
| 2022-11-07 16:30:00 | Nightingale Health's Auditor's Report for financial year 2021-2022 has been published | https://view.news.eu.nasdaq.com/view?id=b688ee766e28c0c40fa9d156ac6709d05&lang=en&src=listed |
| 2022-11-07 16:30:00 | Nightingale Healthin tilintarkastuskertomus tilikaudelta 2021-2022 on julkaistu | https://view.news.eu.nasdaq.com/view?id=b0df72043036a507acbcc118f4eee962a&lang=fi&src=listed |
| 2022-11-17 17:15:00 | Nightingale Health Oyj:n varsinaisen yhtiökokouksen ja hallituksen järjestäytymiskokouksen päätökset | https://view.news.eu.nasdaq.com/view?id=b560d6f3a21e2f665f9623d4a3fada203&lang=fi&src=listed |
| 2022-11-17 17:15:00 | Resolutions of the Annual General Meeting and the Board of Directors' organizational meeting of Nightingale Health Plc | https://view.news.eu.nasdaq.com/view?id=b5a84190f695020cbeb75299ebc4a9499&lang=en&src=listed |
| 2022-11-17 17:20:00 | Change in the publication date of Nightingale Health Plc's half-year financial report for the period 1 July - 31 December 2022 | https://view.news.eu.nasdaq.com/view?id=bb058151f09b461a5bbb7723f2c2d0742&lang=en&src=listed |
| 2022-11-17 17:20:00 | Muutos Nightingale Health Oyj:n puolivuotiskatsauksen 1.7.-31.12.2022 julkaisuajankohtaan | https://view.news.eu.nasdaq.com/view?id=b64a1ca1a704d071804377d65f72344b0&lang=fi&src=listed |
| 2022-12-22 15:15:00 | Nightingale Health Oyj:n A-sarjan osakkeiden muunto B-sarjan osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b2a6c694ed139096208e6b6f49c8b5f17&lang=fi&src=listed |
| 2022-12-22 15:15:00 | Conversion of Nightingale Health Plc's Series A shares to Series B shares | https://view.news.eu.nasdaq.com/view?id=bf91b2f9454b07f8d6cbb848f164e4095&lang=en&src=listed |
| 2023-01-25 07:00:00 | Nightingale Health to open laboratory in the United Kingdom in 2023 | https://view.news.eu.nasdaq.com/view?id=b14a99c1bbc216fb1ff7888d71f74c022&lang=en&src=listed |
| 2023-01-25 07:00:00 | Nightingale Health avaa laboratorion Isossa-Britanniassa vuoden 2023 aikana | https://view.news.eu.nasdaq.com/view?id=b4384c73aebd852130431e965a5cfff84&lang=fi&src=listed |
| 2023-01-31 15:05:00 | Sisäpiiritieto: Nightingale Health on hankkinut maailmanlaajuisen lisenssin Velvet™ verenkeräyslaitteeseen | https://view.news.eu.nasdaq.com/view?id=b40d64f63c19c3137bf8a8fb52a537fd1&lang=fi&src=listed |
| 2023-01-31 15:05:00 | Inside information: Nightingale Health acquires worldwide license for blood self-collection device Velvet™ | https://view.news.eu.nasdaq.com/view?id=b4601d0b8babdfdf23ddc9a722ba4951b&lang=en&src=listed |
| 2023-02-03 08:00:00 | Nightingale Health combines genetics with its unique blood test results in Livit by Nightingale Health service | https://view.news.eu.nasdaq.com/view?id=b695ec50cc7e8e0c6ea0e4ebe8531b2cf&lang=en&src=listed |
| 2023-02-03 08:00:00 | Nightingale Health yhdistää genetiikan ainutlaatuisiin verianalyysituloksiinsa Livit by Nightingale Health -palvelussa | https://view.news.eu.nasdaq.com/view?id=b02c197cbf8443bdf4f6b06b8e544d7a2&lang=fi&src=listed |
| 2023-03-08 12:30:00 | Strateginen yhteistyö Virossa etenee: Nightingale Health on analysoinut Viron Biopankin 200 000 osallistujan näytteet | https://view.news.eu.nasdaq.com/view?id=bf677e4d427c423579ac9e9af2be8aa2a&lang=fi&src=listed |
| 2023-03-08 12:30:00 | Strategic collaboration in Estonia progresses: Nightingale Health completes the analysis of 200000 Estonian Biobank samples | https://view.news.eu.nasdaq.com/view?id=b83a2b65829064a939d4bc3835a712844&lang=en&src=listed |
| 2023-03-15 11:45:00 | Nightingale Health julkaisee 23.3.2023 puolivuotiskatsauksen heinä-joulukuulta 2022 | https://view.news.eu.nasdaq.com/view?id=b760419d044997f2c8da87b1f23503789&lang=fi&src=listed |
| 2023-03-15 11:45:00 | Nightingale Health to publish half-year report for July - December 2022 on 23 March 2023 | https://view.news.eu.nasdaq.com/view?id=bdde151e2d7b39d2eacb8720332c0c7f6&lang=en&src=listed |
| 2023-03-17 11:15:00 | Kutsu Nightingale Health Oyj:n ylimääräiseen yhtiökokoukseen | https://view.news.eu.nasdaq.com/view?id=b252f4a39693b10d611e426f8a14737c0&lang=fi&src=listed |
| 2023-03-17 11:15:00 | Notice to the Extraordinary General Meeting of Nightingale Health Plc | https://view.news.eu.nasdaq.com/view?id=b369f7cd4a7fe0180944296d2c57c5e6e&lang=en&src=listed |
| 2023-03-22 11:00:00 | Nightingale Health Oyj: IFRS:n mukaiset tilintarkastamattomat taloudelliset vertailutiedot puolivuotiskausilta | https://view.news.eu.nasdaq.com/view?id=bdfd496f65c652d631e5ecb08d2c426a3&lang=fi&src=listed |
| 2023-03-22 11:00:00 | Nightingale Health Plc: Unaudited financial information in accordance with IFRS for the comparative half-year periods | https://view.news.eu.nasdaq.com/view?id=bbb4bad97cb93b84e8a80f4c814b381af&lang=en&src=listed |
| 2023-03-23 08:00:00 | Nightingale Health Group's Half-year report 1 July 2022 - 31 December 2022: Commercialization progressing in line with strategy | https://view.news.eu.nasdaq.com/view?id=baacddf0e6babcadee32a8454bb66a366&lang=en&src=listed |
| 2023-03-23 08:00:00 | Nightingale Health -konsernin puolivuotiskatsaus 1.7.2022-31.12.2022: Kaupallistaminen etenee strategian mukaisesti | https://view.news.eu.nasdaq.com/view?id=b403afe7d3e4b9ccb87b3b38a3c84089d&lang=fi&src=listed |
| 2023-03-24 09:00:00 | Nightingale Health Oyj:n päävastuullinen tilintarkastaja vaihtuu | https://view.news.eu.nasdaq.com/view?id=b5879ba1d854b5eca4676ea92cb647f06&lang=fi&src=listed |
| 2023-03-24 09:00:00 | Nightingale Health Plc's Auditor to Change | https://view.news.eu.nasdaq.com/view?id=b0c9c7401392580f8acdd6474c5ccfa03&lang=en&src=listed |
| 2023-04-24 16:10:00 | Nightingale Health Oyj:n ylimääräisen yhtiökokouksen ja hallituksen järjestäytymiskokouksen päätökset | https://view.news.eu.nasdaq.com/view?id=ba735cdf8e3f27e83c33942baa0ea5f67&lang=fi&src=listed |
| 2023-04-24 16:10:00 | Nightingale Health Plc: Resolutions of the Extraordinary General Meeting and the Board of Directors' organizational meeting | https://view.news.eu.nasdaq.com/view?id=ba5d2962cb153c6167b9eb9ecddaaf3c4&lang=en&src=listed |
| 2023-05-08 10:45:00 | Maximilian LeRoux nimitetty Nightingale Health Oyj:n kaupalliseksi johtajaksi | https://view.news.eu.nasdaq.com/view?id=b71c63023ef3bdacdc7a2029be666a5cc&lang=fi&src=listed |
| 2023-05-08 10:45:00 | Maximilian LeRoux appointed as Chief Commercial Officer of Nightingale Health Plc | https://view.news.eu.nasdaq.com/view?id=bbcdc5f062163115674dda2acdfdfd596&lang=en&src=listed |
| 2023-05-23 08:00:00 | Nightingale Healthin teknologian sairastumisriskien tunnistamiskyvylle on myönnetty kuusi patenttia | https://view.news.eu.nasdaq.com/view?id=b827271165b2efd497e01b07aed341e6e&lang=fi&src=listed |
| 2023-05-23 08:00:00 | Nightingale Health has received six patent approvals for its proprietary health risk detection platform | https://view.news.eu.nasdaq.com/view?id=b3297f1954c19f5a2c86517cd332bc96b&lang=en&src=listed |
| 2023-05-31 08:30:00 | Nightingale Health Oyj:n taloudellinen tiedottaminen ja varsinainen yhtiökokous tilikaudella 2023-2024 | https://view.news.eu.nasdaq.com/view?id=b553a4f0123c931ad3ea18912e4a61a20&lang=fi&src=listed |
| 2023-05-31 08:30:00 | Nightingale Health Plc's financial reporting and Annual General Meeting in financial year 2023 - 2024 | https://view.news.eu.nasdaq.com/view?id=be5e1a23441e41d2f8162c45ca7e8f7de&lang=en&src=listed |
| 2023-06-06 08:00:00 | Nightingale Health's strategic collaboration with UK Biobank progresses: Biomarker results of additional 200000 blood samples soon available to researchers globally | https://view.news.eu.nasdaq.com/view?id=bd79a3027279d5f7295a9b347005540a2&lang=en&src=listed |
| 2023-06-06 08:00:00 | Nightingale Healthin strateginen yhteistyö UK Biopankin kanssa etenee: 200 000 verinäytteen analyysitulokset tulevat tutkijoiden saataville ympäri maailman | https://view.news.eu.nasdaq.com/view?id=b7d31648fc53fec4bd4098075bded18ec&lang=fi&src=listed |
| 2023-06-15 08:00:00 | Maailman suurin veren merkkiaineet ja genetiikan yhdistävä väestötutkimus osoittaa Nightingale Healthin riskiennustemallien suorituskyvyn olevan parempi kuin geneettisten riskiennusteiden | https://view.news.eu.nasdaq.com/view?id=b78b7454571b81ed6a67d964cb6cffec9&lang=fi&src=listed |
| 2023-06-15 08:00:00 | World's largest population study combining blood biomarkers and genetics demonstrates Nightingale Health's risk prediction models outperform genetic risk prediction in chronic diseases | https://view.news.eu.nasdaq.com/view?id=bcee73903adcb23bb53c9d88dd5e39905&lang=en&src=listed |
| 2023-06-30 10:20:00 | Sisäpiiritieto: Nightingale Health ja Terveystalo solmivat aiesopimuksen strategisen yhteistyön laajentamisesta | https://view.news.eu.nasdaq.com/view?id=bcf61a60035f109d1334d9075f9aa36b3&lang=fi&src=listed |
| 2023-06-30 10:20:00 | Inside information: Nightingale Health and Terveystalo sign letter of intent to expand strategic partnership | https://view.news.eu.nasdaq.com/view?id=ba7e7d3e617d7a16d3532aa3ec0900dda&lang=en&src=listed |
| 2023-07-03 10:00:00 | Sisäpiiritieto: Päivitys Nightingale Health Oyj:n tilikaudelle 2022-2023 asetetuista liiketoimintatavoitteista | https://view.news.eu.nasdaq.com/view?id=b450d46fee0b102d55e5a893ca1bd8bb3&lang=fi&src=listed |
| 2023-07-03 10:00:00 | Inside information: Update on Nightingale Health Plc's business targets for financial year 2022 - 2023 | https://view.news.eu.nasdaq.com/view?id=b7be978175184ef584dc21fda4e9fc154&lang=en&src=listed |
| 2023-07-06 15:00:00 | Conversion of Nightingale Health Plc's EMP shares to Series B shares | https://view.news.eu.nasdaq.com/view?id=bbbc143e79857130066c13a4cff6fe18c&lang=en&src=listed |
| 2023-07-06 15:00:00 | Nightingale Health Oyj:n EMP-osakkeiden muunto B-sarjan osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b09909979e543ad42e8b36d7785b86ddc&lang=fi&src=listed |
| 2023-08-17 08:55:00 | Nightingale Health rolls out remote blood collection kit for medical research and clinical trials | https://view.news.eu.nasdaq.com/view?id=baa2ef3d5055eb6de25c19aad204558f5&lang=en&src=listed |
| 2023-08-17 08:55:00 | Nightingale Health lanseeraa Velvet™-verenkeräyslaitteen lääketieteellisten ja kliinisten tutkimusten käyttöön osana analyysipalveluaan | https://view.news.eu.nasdaq.com/view?id=b5d775ef4de93b602bacf94856a19d7e8&lang=fi&src=listed |
| 2023-08-30 17:35:00 | Sisäpiiritieto: Terveystalo ottaa käyttöön Nightingale Healthin verianalyysiteknologian työterveydessä säännöllisesti tehtävissä terveystarkastuksissa | https://view.news.eu.nasdaq.com/view?id=b32d9dfce35ac4f85286cabcada40d0d4&lang=fi&src=listed |
| 2023-08-30 17:35:00 | Inside information: Terveystalo adopts Nightingale Health's blood analysis technology in regular health checks in occupational health | https://view.news.eu.nasdaq.com/view?id=b273eec0ba7108906ddcc4a1390ab9b4f&lang=en&src=listed |
| 2023-09-06 07:30:00 | Nightingale Health analysoi verinäytteitä johtavalle yhdysvaltalaiselle terveydenhuollon toimijalle | https://view.news.eu.nasdaq.com/view?id=ba147cfc82cdeacdcba5e8af954789682&lang=fi&src=listed |
| 2023-09-06 07:30:00 | Nightingale Health to provide blood sample analysis service for a large U.S. healthcare system | https://view.news.eu.nasdaq.com/view?id=b3ea3a691194869386bb609aa05a589a9&lang=en&src=listed |
| 2023-09-11 11:30:00 | Inside information: Nightingale Health updates its strategy with a focus on B2B and B2G markets | https://view.news.eu.nasdaq.com/view?id=bdf627132da5347b326d824b7b71ed955&lang=en&src=listed |
| 2023-09-11 11:30:00 | Sisäpiiritieto: Nightingale Health päivittää strategiansa ja keskittyy jatkossa liiketoimintoihin yritysasiakkaiden ja julkisen sektorin kanssa | https://view.news.eu.nasdaq.com/view?id=bc772ec9ecb0a5c24e8b6b070e6711a50&lang=fi&src=listed |
| 2023-09-14 13:30:00 | Nightingale Health to publish Financial Statements Release for financial year July 2022-June 2023 on 28 September 2023 | https://view.news.eu.nasdaq.com/view?id=bb69fa1b35078b6a7b9cc44417c009f1e&lang=en&src=listed |
| 2023-09-14 13:30:00 | Nightingale Health julkaisee 28.9.2023 tilinpäätöstiedotteen kaudelta heinäkuu 2022-kesäkuu 2023 | https://view.news.eu.nasdaq.com/view?id=b5d34bd25ee4707b61769bac543b1e474&lang=fi&src=listed |
| 2023-09-19 09:15:00 | Nightingale Healthin Iso-Britannian laboratorio tulee sijaitsemaan Porton Science Parkissa | https://view.news.eu.nasdaq.com/view?id=b6c969cf6b60ec96e7375031f1ae09bb7&lang=fi&src=listed |
| 2023-09-19 09:15:00 | Nightingale Health's laboratory in the United Kingdom to be situated in Porton Science Park | https://view.news.eu.nasdaq.com/view?id=b1b6c9ec460e5ea0dac3e956ad7b545f1&lang=en&src=listed |
| 2023-09-26 08:00:00 | Nightingale Health vahvistaa IP-salkkuaan kolmella uudella patentilla | https://view.news.eu.nasdaq.com/view?id=b596ee3fd8248be2fce5f00afcb884e6f&lang=fi&src=listed |
| 2023-09-26 08:00:00 | Nightingale Health receives three new patents further strengthening its IP portfolio | https://view.news.eu.nasdaq.com/view?id=bc9d081bf2d6c5f1fb912d3072d5035da&lang=en&src=listed |
| 2023-09-28 08:00:00 | Nightingale Health Oyj tilinpäätöstiedote 1.7.2022-30.6.2023 | https://view.news.eu.nasdaq.com/view?id=b11701fcb85779ade3a2afd2d4723e8bf&lang=fi&src=listed |
| 2023-09-28 08:00:00 | Nightingale Health Plc Financial Statements Release 1 July 2022 - 30 June 2023 | https://view.news.eu.nasdaq.com/view?id=b40b19dcd0b1824fb2e23d60ed91c586c&lang=en&src=listed |
| 2023-10-16 14:00:00 | Nightingale Healthin hallitus on päättänyt uusista osakepohjaisista kannustinohjelmista sekä muutoksista nykyisiin osakepohjaisiin kannustinohjelmiin | https://view.news.eu.nasdaq.com/view?id=b87c754c14958aa9bcbf399c672af9068&lang=fi&src=listed |
| 2023-10-16 14:00:00 | Nightingale Health's Board of Directors resolved on new share-based incentive programs and amendments to existing incentive programs | https://view.news.eu.nasdaq.com/view?id=b8b800ae9d539c8176668de582f6e6533&lang=en&src=listed |
| 2023-10-19 08:00:00 | Nightingale Health's Annual Report for financial year 2022-2023 has been published | https://view.news.eu.nasdaq.com/view?id=be0f7be10b6d8f725ab56bd64baa8a74d&lang=en&src=listed |
| 2023-10-19 08:00:00 | Nightingale Healthin vuosikertomus tilikaudelta 2022-2023 on julkaistu | https://view.news.eu.nasdaq.com/view?id=b6e2f99d20da8c722089184081062c0c2&lang=fi&src=listed |
| 2023-10-19 14:00:00 | Kutsu Nightingale Health Oyj:n varsinaiseen yhtiökokoukseen | https://view.news.eu.nasdaq.com/view?id=bbc6683b87c616b557c0aeb5da8d4d59a&lang=fi&src=listed |
| 2023-10-19 14:00:00 | Notice to the Annual General Meeting of Nightingale Health Plc | https://view.news.eu.nasdaq.com/view?id=b37b24874c6411319bccb1e71b509cb3d&lang=en&src=listed |
| 2023-11-01 09:45:00 | Nightingale Healthin tutkimustiivistelmä sydänsairauksien ennaltaehkäisystä voittanut Yhdysvaltain Sydänyhdistyksen Paul Dudley White International Scholar Award -palkinnon | https://view.news.eu.nasdaq.com/view?id=b19fee14a75f516f9da0027a6596bdca6&lang=fi&src=listed |
| 2023-11-01 09:45:00 | Research study abstract by Nightingale Health on heart disease prevention wins American Heart Association's Paul Dudley White International Scholar Award | https://view.news.eu.nasdaq.com/view?id=b435b2e53e6f43619ed0e501ef8aae6c0&lang=en&src=listed |
| 2023-11-15 08:15:00 | Sisäpiiritieto: Nightingale Health ja Innoquest Diagnostics ovat solmineet yhteistyösopimuksen jonka myötä Nightingale Healthin teknologian saatavuus laajenee Kaakkois-Aasian markkinoille | https://view.news.eu.nasdaq.com/view?id=bb5f1d0328b3167f5e34b4f8247965c78&lang=fi&src=listed |
| 2023-11-15 08:15:00 | Inside information: Nightingale Health and Innoquest Diagnostics enter into collaboration agreement to make Nightingale Health's technology accessible in the Southeast Asia region | https://view.news.eu.nasdaq.com/view?id=bd0ed078779fd280776b60952db7a83c8&lang=en&src=listed |
| 2023-11-16 16:30:00 | Resolutions of the Annual General Meeting and the Board of Directors' organizational meeting of Nightingale Health Plc | https://view.news.eu.nasdaq.com/view?id=bb1b7f264b882a8c33026fec61533138c&lang=en&src=listed |
| 2023-11-16 16:30:00 | Nightingale Health Oyj:n varsinaisen yhtiökokouksen ja hallituksen järjestäytymiskokouksen päätökset | https://view.news.eu.nasdaq.com/view?id=b8affba6cffdf92326023d6236711c296&lang=fi&src=listed |
| 2023-11-27 17:00:00 | Change in Nightingale Health Plc's Management Team | https://view.news.eu.nasdaq.com/view?id=b620cab14303f1cef6bc0f9ed11d622d7&lang=en&src=listed |
| 2023-11-27 17:00:00 | Muutos Nightingale Health Oyj:n johtoryhmässä | https://view.news.eu.nasdaq.com/view?id=bfa7d7997e1c4d0a1cbd5bc64ea440238&lang=fi&src=listed |
| 2023-12-13 07:30:00 | Nightingale Healthin analysoimat 500 000 UK Biopankin verinäytettä luovat maailman suurimman veren merkkiaineiden tietokannan kroonisten sairauksien tutkimukseen ja ennaltaehkäisyyn | https://view.news.eu.nasdaq.com/view?id=b8d483e822510b7a6ab42f89fac7ee9da&lang=fi&src=listed |
| 2023-12-13 07:30:00 | Nightingale Health completes the analysis of all 500000 UK Biobank samples creating the world's largest blood biomarker database for chronic disease research and prevention | https://view.news.eu.nasdaq.com/view?id=b73b57b0e0efa4b577b0861845c606a60&lang=en&src=listed |
| 2024-01-02 08:45:00 | Terveystalo begins using Nightingale Health's blood analysis technology in regular health checks in occupational health | https://view.news.eu.nasdaq.com/view?id=b820f91435f1915b3671a2a32ec05126d&lang=en&src=listed |
| 2024-01-02 08:45:00 | Terveystalo on aloittanut Nightingale Healthin verianalyysiteknologian käytön työterveydessä säännöllisesti tehtävissä terveystarkastuksissa | https://view.news.eu.nasdaq.com/view?id=b812050d967a4140232336dd81df1a320&lang=fi&src=listed |
| 2024-01-19 09:00:00 | Nightingale Health liittyy Radical Health Festival Helsingin perustajakumppaniksi | https://view.news.eu.nasdaq.com/view?id=b3bf1ea54a2fb711464f9113fc1f14ff5&lang=fi&src=listed |
| 2024-01-19 09:00:00 | Nightingale Health joins Radical Health Festival Helsinki as Founding Partner to promote urgent global need for preventative health | https://view.news.eu.nasdaq.com/view?id=b700b07cdf415bda781c66c9460cc4aa7&lang=en&src=listed |
| 2024-01-31 07:00:00 | Nightingale Health receives five new patents for its proprietary health risk detection capability | https://view.news.eu.nasdaq.com/view?id=b5a289145ee3657a8767e1d51462686a6&lang=en&src=listed |
| 2024-01-31 07:00:00 | Nightingale Healthin teknologian sairastumisriskien tunnistamiskyvylle viisi uutta patenttia | https://view.news.eu.nasdaq.com/view?id=b224eda5e0de6999b02b9355903eb59b5&lang=fi&src=listed |
| 2024-02-23 08:00:00 | Nightingale Healthille viranomaishyväksyntä terveydenhuollon käyttöön Singaporessa | https://view.news.eu.nasdaq.com/view?id=b40dce4f7a75dd6d2927e7a5ad295a0a0&lang=fi&src=listed |
| 2024-02-23 08:00:00 | Nightingale Health receives regulatory approval for healthcare use from Health Sciences Authority in Singapore | https://view.news.eu.nasdaq.com/view?id=bee7f4357e3d4306e9283a4e83c66bfe1&lang=en&src=listed |
| 2024-02-28 13:15:00 | Nightingale Health julkaisee 7.3.2024 puolivuotiskatsauksen heinä-joulukuulta 2023 | https://view.news.eu.nasdaq.com/view?id=bc88b95a900c237039a9468c87ce22149&lang=fi&src=listed |
| 2024-02-28 13:15:00 | Nightingale Health to publish half-year report for July - December 2023 on 7 March 2024 | https://view.news.eu.nasdaq.com/view?id=b4983e0bc54d9340c02ce26d5c713675a&lang=en&src=listed |
| 2024-03-07 07:00:00 | Nightingale Health's Half-year report: Healthcare implementations progressing in Finland and Singapore | https://view.news.eu.nasdaq.com/view?id=bbecdf692c15b85f3e41dba019ce45536&lang=en&src=listed |
| 2024-03-07 07:00:00 | Nightingale Healthin puolivuotiskatsaus: Suomessa ja Singaporessa käyttöönotot terveydenhuollossa etenevät | https://view.news.eu.nasdaq.com/view?id=bdc03416b6137e1eb42149885e4890507&lang=fi&src=listed |
| 2024-03-07 08:00:00 | Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc | https://view.news.eu.nasdaq.com/view?id=ba6cb6fe5ce6fe9bf2392baac5e83bffb&lang=en&src=listed |
| 2024-03-07 08:00:00 | Sisäpiiritieto: Nightingale Health vahvistaa Japanin liiketoimintaansa hankkimalla Welltus Inc:n | https://view.news.eu.nasdaq.com/view?id=b58dcdd23c685a4b868d4becdb9b325e0&lang=fi&src=listed |
| 2024-03-07 14:30:00 | Täydennystiedote: Sisäpiiritieto: Nightingale Health vahvistaa Japanin liiketoimintaansa hankkimalla Welltus Inc:n | https://view.news.eu.nasdaq.com/view?id=bf43a5bc800f3960d3818fc44248b9a18&lang=fi&src=listed |
| 2024-03-07 14:30:00 | Supplement to the release: Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc | https://view.news.eu.nasdaq.com/view?id=bbacb4965296b56fab0f04e94abae1564&lang=en&src=listed |
| 2024-03-19 07:00:00 | Nightingale Health tehnyt sopimuksen ugandalaiseen väestötutkimukseen kuuluvien verinäytteiden analysoinnista | https://view.news.eu.nasdaq.com/view?id=b636bd8e845ea542ab56856b02ef6d4b9&lang=fi&src=listed |
| 2024-03-19 07:00:00 | Nightingale Health's technology used to analyze Uganda's General Population Cohort (GPC) | https://view.news.eu.nasdaq.com/view?id=bd692e3c441313cbe61476f7366fc9f78&lang=en&src=listed |
| 2024-03-20 16:00:00 | Nightingale Health Oyj:n EMP-osakkeiden muunto B-sarjan osakkeiksi | https://view.news.eu.nasdaq.com/view?id=ba505f30a09e3537c2fd5d814a5620b2d&lang=fi&src=listed |
| 2024-03-20 16:00:00 | Conversion of Nightingale Health Plc's EMP shares to Series B shares | https://view.news.eu.nasdaq.com/view?id=b3a3027bd3f4f7b84f50e357cb19bd9a1&lang=en&src=listed |
| 2024-03-21 05:50:00 | Korjaustiedote: Nightingale Health Oyj:n EMP-osakkeiden muunto B-sarjan osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b99b201fdaaa8df88c96af6eba3512e44&lang=fi&src=listed |
| 2024-03-21 05:50:00 | Correction: Conversion of Nightingale Health Plc's EMP shares to Series B shares | https://view.news.eu.nasdaq.com/view?id=bf056a6401b1a291d5a01de13b34fcd21&lang=en&src=listed |
| 2024-03-29 08:00:00 | Nightingale Health has completed the acquisition of Welltus Inc | https://view.news.eu.nasdaq.com/view?id=b58837115fa89246e555306587e76e782&lang=en&src=listed |
| 2024-03-29 08:00:00 | Nightingale Health on saattanut päätökseen Welltus Inc:n yrityskaupan | https://view.news.eu.nasdaq.com/view?id=bddfb8b69e8a394ba8874e9e7f45bf1e9&lang=fi&src=listed |
| 2024-04-12 06:15:00 | Inside Information: Nightingale Health enters into agreement to analyze 50000 blood samples with Kaiser Foundation Health Plan Inc. | https://view.news.eu.nasdaq.com/view?id=b5325fc68ed8631c83fe70d308ce6369a&lang=en&src=listed |
| 2024-04-12 06:15:00 | Sisäpiiritieto: Nightingale Health ja Kaiser Foundation Health Plan Inc. ovat tehneet sopimuksen 50 000 verinäytteen analysoinnista | https://view.news.eu.nasdaq.com/view?id=b5d9b0e3f6d7b09e6f9f9c07eec2c4ed5&lang=fi&src=listed |
| 2024-04-12 11:45:00 | Täydennystiedote: Sisäpiiritieto: Nightingale Health ja Kaiser Foundation Health Plan Inc. ovat tehneet sopimuksen 50 000 verinäytteen analysoinnista | https://view.news.eu.nasdaq.com/view?id=b764fb664a0328b121edb33b28762cf99&lang=fi&src=listed |
| 2024-04-12 11:45:00 | Supplement to the release: Inside Information: Nightingale Health enters into agreement to analyze 50000 blood samples with Kaiser Foundation Health Plan Inc. | https://view.news.eu.nasdaq.com/view?id=b71411e2d4345f4dfc3e9e6de1b78e27c&lang=en&src=listed |
| 2024-04-16 07:45:00 | Nightingale Health avaa Yhdysvaltoihin laboratorion jonka ensimmäinen asiakas on Weill Cornell Medicine | https://view.news.eu.nasdaq.com/view?id=be1577ee94c6fc5b81b864a877b32d75b&lang=fi&src=listed |
| 2024-04-16 07:45:00 | Nightingale Health to establish a laboratory in the United States with Weill Cornell Medicine as the first customer | https://view.news.eu.nasdaq.com/view?id=bf28053f23c3d889d2a863ff4104331e9&lang=en&src=listed |
| 2024-04-25 10:50:00 | Inside information: Nightingale Health achieves one of its business targets for this financial year by winning contracts in medical research with a total contract value of at least EUR 3.2 million | https://view.news.eu.nasdaq.com/view?id=bd9979b1cf2c26677b1d10261956d30dd&lang=en&src=listed |
| 2024-04-25 10:50:00 | Sisäpiiritieto: Nightingale Health on saavuttanut yhden tämän tilikauden tavoitteistaan solmimalla sopimuksia vähintään 32 miljoonan euron arvosta lääketieteellisen tutkimuksen liiketoiminta-alueella | https://view.news.eu.nasdaq.com/view?id=b3207d9313557ffe7eae19db45c40cc53&lang=fi&src=listed |
| 2024-05-21 10:15:00 | Nightingale Health julkistaa uudistuneet B2B ja B2G strategiansa mukaiset verkkosivut | https://view.news.eu.nasdaq.com/view?id=b5ddf0cdcbe48f88db9e39fb92f666d86&lang=fi&src=listed |
| 2024-05-21 10:15:00 | Nightingale Health launches new website aligned with the B2B and B2G strategy | https://view.news.eu.nasdaq.com/view?id=b41eb93593e024be299ea4d09f57ab921&lang=en&src=listed |
| 2024-05-23 09:45:00 | Nightingale Healthin hallitus on päättänyt työntekijöiden optio-ohjelman optioiden merkintäajan pidentämisestä | https://view.news.eu.nasdaq.com/view?id=ba019f9dc782ea47d3fe6f495a009d758&lang=fi&src=listed |
| 2024-05-23 09:45:00 | Nightingale Health's Board of Directors extended the subscription period of employee option rights | https://view.news.eu.nasdaq.com/view?id=b32b1a827eeb7d2a424aa2d1262c826f4&lang=en&src=listed |
| 2024-06-06 08:30:00 | Modernia terveysteknologiaa hyödyntävä terveystarkastus tarjoaa paremman perustan kansanterveydelle | https://view.news.eu.nasdaq.com/view?id=b5d318a92c4e5618c2c18ecde9f33b40a&lang=fi&src=listed |
| 2024-06-06 08:30:00 | Health check based on advanced blood analysis technology builds a better foundation for public health | https://view.news.eu.nasdaq.com/view?id=b5eac8a90faae6ca83dee88dfb96d1323&lang=en&src=listed |
| 2024-06-11 13:50:00 | Nightingale Health Oyj:n A-sarjan osakkeiden muunto B-sarjan osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b09d082d46500a40e7e02e7bc629a3ed2&lang=fi&src=listed |
| 2024-06-11 13:50:00 | Conversion of Nightingale Health Plc's Series A shares to Series B shares | https://view.news.eu.nasdaq.com/view?id=b9891f8bb034d1665c5b88f4dfb020c29&lang=en&src=listed |
| 2024-06-18 14:20:00 | Disclosure under Chapter 9 Section 10 of the Securities Markets Act (Antti Kangas) | https://view.news.eu.nasdaq.com/view?id=bd17f4e6bdd5aead16b8acf265d38ec58&lang=en&src=listed |
| 2024-06-18 14:20:00 | Arvopaperimarkkinalain 9 luvun 10 pykälän mukainen ilmoitus omistusosuudesta (Antti Kangas) | https://view.news.eu.nasdaq.com/view?id=b919e15bde7bc1d52a453e87321f75378&lang=fi&src=listed |
| 2024-06-18 16:05:00 | Arvopaperimarkkinalain 9 luvun 10 pykälän mukainen ilmoitus omistusosuudesta (Teemu Suna) | https://view.news.eu.nasdaq.com/view?id=b9b1981bb3f8e059da8f9c014e9e08ba8&lang=fi&src=listed |
| 2024-06-18 16:05:00 | Disclosure under Chapter 9 Section 10 of the Securities Markets Act (Teemu Suna) | https://view.news.eu.nasdaq.com/view?id=b0ea62ca871bfac6ba4b5c22f1ee49631&lang=en&src=listed |
| 2024-06-18 16:15:00 | Disclosure under Chapter 9 Section 10 of the Securities Markets Act (Pasi Soininen) | https://view.news.eu.nasdaq.com/view?id=ba0f276438c59294a7ca0449dc1af42c2&lang=en&src=listed |
| 2024-06-18 16:15:00 | Arvopaperimarkkinalain 9 luvun 10 pykälän mukainen ilmoitus omistusosuudesta (Pasi Soininen) | https://view.news.eu.nasdaq.com/view?id=bb09317f148ad045436c5b12a324e59c3&lang=fi&src=listed |
| 2024-06-18 16:25:00 | Arvopaperimarkkinalain 9 luvun 10 pykälän mukainen ilmoitus omistusosuudesta (Cor Group Oy) | https://view.news.eu.nasdaq.com/view?id=bdde72f6919d52764568c18409bb8187b&lang=fi&src=listed |
| 2024-06-18 16:25:00 | Disclosure under Chapter 9 Section 10 of the Securities Markets Act (Cor Group Oy) | https://view.news.eu.nasdaq.com/view?id=bb09f3f73108ee23a9ab7558a5cd51e77&lang=en&src=listed |
| 2024-06-27 13:45:00 | Nightingale Health on hankkinut täydet immateriaalioikeudet Velvet™ verenkeräyslaitteeseen varmistaakseen asemansa ainoana kokonaisvaltaisen ratkaisun tarjoajana itse tehtävien veritestien markkinassa | https://view.news.eu.nasdaq.com/view?id=b0ec826c385def8045c973f3464ada476&lang=fi&src=listed |
| 2024-06-27 13:45:00 | Nightingale Health acquires all intellectual property assets of the Velvet™ blood collection device and secures its position as the sole provider of a fully integrated remote health check solution | https://view.news.eu.nasdaq.com/view?id=b5eea6f5b906d1930ca796c125a67c8a8&lang=en&src=listed |
| 2024-06-27 15:15:00 | Nightingale Health ja ZOE laajentavat tutkimusyhteistyötään ottamalla käyttöön verenkeräyslaitteen | https://view.news.eu.nasdaq.com/view?id=b645ea9345cbe39c5fb181324b6bb40cc&lang=fi&src=listed |
| 2024-06-27 15:15:00 | Nightingale Health and ZOE expand research collaboration to include self-collected blood samples | https://view.news.eu.nasdaq.com/view?id=b4e2c9e6d724eb85e6d251560267f685b&lang=en&src=listed |
| 2024-06-28 08:35:00 | Sisäpiiritieto: Nightingale Health ja Boston Heart Diagnostics sopivat strategisesta yhteistyöstä Nightingalen Health Check -palvelun myymisestä Yhdysvalloissa | https://view.news.eu.nasdaq.com/view?id=be665814bb607e4c83876e30f7dc74de0&lang=fi&src=listed |
| 2024-06-28 08:35:00 | Inside information: Nightingale Health and Boston Heart Diagnostics enter strategic partnership to sell Nightingale's Health Check in the United States | https://view.news.eu.nasdaq.com/view?id=b1a9a4ce6a166196ef8d3db60d42709bb&lang=en&src=listed |
| 2024-06-28 13:00:00 | Inside Information: 23andMe and Nightingale Health Announce Strategic Collaboration to Pilot Blood Biomarker Panel | https://view.news.eu.nasdaq.com/view?id=bfe512bd45f1a22b0051f4423bf5477a7&lang=en&src=listed |
| 2024-06-28 13:00:00 | Sisäpiiritieto: 23andMe ja Nightingale Health julkistavat strategisen yhteistyön ja käynnistävät verianalyysin pilotoinnin | https://view.news.eu.nasdaq.com/view?id=baea5010285928f008c5f6122b986691c&lang=fi&src=listed |
| 2024-07-03 15:35:00 | Tiivistelmä tilikaudesta 7/2023-6/2024: Nightingale Healthille useita läpimurtoja teknologian käyttöönotossa terveydenhuollossa | https://view.news.eu.nasdaq.com/view?id=b8e0b6b5c44535491f74808025a6a26b5&lang=fi&src=listed |
| 2024-07-03 15:35:00 | Summary of Financial Year 7/2023 - 6/2024: Nightingale Health achieved several breakthroughs in adopting the company's technology in healthcare | https://view.news.eu.nasdaq.com/view?id=bc3c449cf71ec062199bb30e3bcb00422&lang=en&src=listed |
| 2024-08-06 17:00:00 | Nightingale Health and U.S.-based Phenome Health announce a partnership to strive towards the most transformational change in the history of healthcare | https://view.news.eu.nasdaq.com/view?id=b6b13c10c0e22f09cde71da270d6de655&lang=en&src=listed |
| 2024-08-06 17:00:00 | Nightingale Health ja yhdysvaltalainen Phenome Health julkistavat yhteistyön tavoitteenaan edistää merkittävintä muutosta terveydenhuollon historiassa | https://view.news.eu.nasdaq.com/view?id=b801e7c374fa48ede2d088505797e7708&lang=fi&src=listed |
| 2024-08-20 08:15:00 | Nightingale Health receives additional regulatory approval for healthcare use from Health Sciences Authority in Singapore | https://view.news.eu.nasdaq.com/view?id=bfe67080989efe42e850181b39e9da784&lang=en&src=listed |
| 2024-08-20 08:15:00 | Nightingale Healthille toinen viranomaishyväksyntä terveydenhuollon käyttöön Singaporessa | https://view.news.eu.nasdaq.com/view?id=b3405ec468a16bbef2648e9aba72aa892&lang=fi&src=listed |
| 2024-08-20 08:45:00 | Nightingale Health attains UKCA marking for its blood analysis technology to bring its technology to healthcare use in the United Kingdom | https://view.news.eu.nasdaq.com/view?id=b4716ea24c0d28b6701520eed74843ad7&lang=en&src=listed |
| 2024-08-20 08:45:00 | Nightingale Healthin verianalyysiteknologialle UKCA-merkintä mahdollistamaan yhtiön teknologian käytön terveydenhuollossa Isossa-Britanniassa | https://view.news.eu.nasdaq.com/view?id=b1c0adc84c9b6ab63fa9448f150dfd4d0&lang=fi&src=listed |
| 2024-09-05 13:30:00 | Nightingale Health julkaisee 20.9.2024 tilinpäätöstiedotteen kaudelta heinäkuu 2023 - kesäkuu 2024 | https://view.news.eu.nasdaq.com/view?id=bb2f1473a5a1e3561fce87a26fb92f450&lang=fi&src=listed |
| 2024-09-05 13:30:00 | Nightingale Health to publish Financial Statements Release for financial year July 2023 - June 2024 on 20 September 2024 | https://view.news.eu.nasdaq.com/view?id=b0576ba7fd3fdb2929ec984520004d9b2&lang=en&src=listed |
| 2024-09-19 12:00:00 | Nightingale Healthille kolmas viranomaishyväksyntä terveydenhuollon käyttöön Singaporessa | https://view.news.eu.nasdaq.com/view?id=bf905007989a2faa2c77dc8a1c2ad2be8&lang=fi&src=listed |
| 2024-09-19 12:00:00 | Nightingale Health receives third regulatory approval for healthcare use from Health Sciences Authority in Singapore | https://view.news.eu.nasdaq.com/view?id=bf7472be27bbfd95a4efe3032f8ad6ece&lang=en&src=listed |
| 2024-09-20 08:00:00 | Nightingale Health Oyj tilinpäätöstiedote 1.7.2023-30.6.2024 | https://view.news.eu.nasdaq.com/view?id=bf7726b9327bd84fce367ebe120ddffe0&lang=fi&src=listed |
| 2024-09-20 08:00:00 | Nightingale Health Plc Financial Statements Release 1 July 2023 - 30 June 2024 | https://view.news.eu.nasdaq.com/view?id=bd3ed4e3e2aad4ebbb6257f7378e9563b&lang=en&src=listed |
| 2024-09-20 12:45:00 | Nightingale Health's Board of Directors resolved on amendment to CEO's incentive program | https://view.news.eu.nasdaq.com/view?id=b696fca0e661e9b961edf0618b5c98c57&lang=en&src=listed |
| 2024-09-20 12:45:00 | Nightingale Healthin hallitus on päättänyt muutoksesta toimitusjohtajan osakepohjaiseen kannustinohjelmaan | https://view.news.eu.nasdaq.com/view?id=b1566b4f0e79f4b54f8f2a03b75939a0e&lang=fi&src=listed |
| 2024-10-09 13:30:00 | Nightingale Health Oyj:n A-sarjan osakkeiden muunto B-sarjan osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b4bbeac130cb3f6db3c56f2def4932c51&lang=fi&src=listed |
| 2024-10-09 13:30:00 | Conversion of Nightingale Health Plc's Series A shares to Series B shares | https://view.news.eu.nasdaq.com/view?id=b1aec9a720ef8bc6c2714efe26fced8c5&lang=en&src=listed |
| 2024-10-10 08:00:00 | Nightingale Health's Annual Report for financial year 2023-2024 has been published | https://view.news.eu.nasdaq.com/view?id=b13be24c4d1f563736fc4a26a9ec21d51&lang=en&src=listed |
| 2024-10-10 08:00:00 | Nightingale Healthin vuosikertomus tilikaudelta 2023-2024 on julkaistu | https://view.news.eu.nasdaq.com/view?id=b390bb383c9f61fd42006034b831b641b&lang=fi&src=listed |
| 2024-10-10 12:00:00 | Kutsu Nightingale Health Oyj:n varsinaiseen yhtiökokoukseen | https://view.news.eu.nasdaq.com/view?id=b328b979f4c5da5adc2fca2692d4ade66&lang=fi&src=listed |
| 2024-10-10 12:00:00 | Notice to the Annual General Meeting of Nightingale Health Plc | https://view.news.eu.nasdaq.com/view?id=b451a2de080e6e870f6bc5174e67c0d4d&lang=en&src=listed |
| 2024-10-30 08:35:00 | Nightingale Health and Boston Heart Diagnostics have successfully completed their pilot and move to the production phase expanding the use of Nightingale's Health Check in the US | https://view.news.eu.nasdaq.com/view?id=bc90195623f2676ff7fdf2167e778cba1&lang=en&src=listed |
| 2024-10-30 08:35:00 | Nightingalen Health Checkin pilotointi Boston Heart Diagnosticsin kanssa on toteutettu onnistuneesti ja osapuolet ovat sopineet yhteistyön laajentamisesta tuotantovaiheeseen myynnin laajentamiseksi | https://view.news.eu.nasdaq.com/view?id=bb96563d1911c96022df5534b60fccd14&lang=fi&src=listed |
| 2024-11-06 08:45:00 | Renowned international expert in medicine Dr. Charles Alessi joins Nightingale Health UK as Chief Medical Officer | https://view.news.eu.nasdaq.com/view?id=b4d3d06895cc9bdcfa5fbcd59bc080ee2&lang=en&src=listed |
| 2024-11-06 08:45:00 | Kansainvälisesti arvostettu lääketieteen asiantuntija Charles Alessi Nightingale Health UK:n lääketieteelliseksi johtajaksi | https://view.news.eu.nasdaq.com/view?id=bee8ee72e022020a54114a0110f458b0b&lang=fi&src=listed |
| 2024-11-08 16:00:00 | Nightingale Health Oyj:n varsinaisen yhtiökokouksen ja hallituksen järjestäytymiskokouksen päätökset | https://view.news.eu.nasdaq.com/view?id=b0ffe41d4d5a37189496c933cca5be1ee&lang=fi&src=listed |
| 2024-11-08 16:00:00 | Resolutions of the Annual General Meeting and the Board of Directors' organizational meeting of Nightingale Health Plc | https://view.news.eu.nasdaq.com/view?id=ba991adc8a639b773ae41fc9254f63b3c&lang=en&src=listed |
| 2024-11-14 08:15:00 | Nightingale Health Asialle on myönnetty ISO 13485:2016 sertifikaatti Singaporessa - valmius palvelun lanseeraamiseen saavutettu | https://view.news.eu.nasdaq.com/view?id=b31a1b78e194c9e8c914d9e81386fcfc3&lang=fi&src=listed |
| 2024-11-14 08:15:00 | Nightingale Health Asia achieves ISO 13485:2016 certification and completes regulatory readiness to launch its blood testing service in Singapore | https://view.news.eu.nasdaq.com/view?id=b2d18008c2fbca0f026c3d1c6ecc4223a&lang=en&src=listed |
| 2024-11-27 13:20:00 | Inside information: Nightingale Health is investigating the transfer of its B shares to the Main Market of Nasdaq Helsinki and adding the OTCQX market as an additional trading venue in the U.S. | https://view.news.eu.nasdaq.com/view?id=b664a2019d6f3b991f2f4daece3545dee&lang=en&src=listed |
| 2024-11-27 13:20:00 | Sisäpiiritieto: Nightingale Health Oyj selvittää B-sarjan osakkeensa siirtämistä Nasdaq Helsingin päälistalle sekä kaupankäynnin aloittamista OTCQX-markkinalla Yhdysvalloissa | https://view.news.eu.nasdaq.com/view?id=b2427b2bceaec4698db5eeae3f7f38ceb&lang=fi&src=listed |
| 2024-11-29 10:30:00 | Nightingale Healthin Singaporen laboratorio avautuu | https://view.news.eu.nasdaq.com/view?id=bb675ca8e2fd6d7bc82b266a5e8b1326f&lang=fi&src=listed |
| 2024-11-29 10:30:00 | Nightingale Health announces opening of its Singapore laboratory | https://view.news.eu.nasdaq.com/view?id=b992f04bea6b118229b761c67d44b9438&lang=en&src=listed |
| 2024-12-04 09:00:00 | Study published in Nature Communications: Nightingale Health outperforms genetic testing in chronic disease risk detection and makes the promise of preventative health a reality | https://view.news.eu.nasdaq.com/view?id=b7173caf62eee74acecf57b07df54afd9&lang=en&src=listed |
| 2024-12-04 09:00:00 | Nature Communications -julkaisu: Nightingale Health tunnistaa kroonisten sairauksien riskit genetiikan riskitestejä paremmin ja mahdollistaa ennaltaehkäisevän terveyden lupausten toteuttamisen | https://view.news.eu.nasdaq.com/view?id=b119925b67157aafdaa223aee9cb01675&lang=fi&src=listed |
| 2024-12-13 14:50:00 | Nightingale Health Oyj:n B-osakkeiden merkintä optio-oikeuksilla | https://view.news.eu.nasdaq.com/view?id=b9b3274058d45c12d59516de0c2562956&lang=fi&src=listed |
| 2024-12-13 14:50:00 | Nightingale Health Plc: Subscription of Series B shares with option rights | https://view.news.eu.nasdaq.com/view?id=b6290bd5208d3f4556e6f741e2372de26&lang=en&src=listed |
| 2024-12-18 20:35:00 | Nightingale Health Oyj:n osakkeelle LP-markkinatakaus Lago Kapital Oy:ltä | https://view.news.eu.nasdaq.com/view?id=bb56d416a7a6ef41a42fc3c298490dc40&lang=fi&src=listed |
| 2024-12-18 20:35:00 | Nightingale Health Plc appoints Lago Kapital as liquidity provider | https://view.news.eu.nasdaq.com/view?id=b8f601b7a18280effa986595b5d96c165&lang=en&src=listed |
| 2024-12-23 13:00:00 | Conversion of Nightingale Health Plc's EMP shares to Series B shares | https://view.news.eu.nasdaq.com/view?id=b236b0cdd78e96f4db0e7596f272c1888&lang=en&src=listed |
| 2024-12-23 13:00:00 | Nightingale Health Oyj:n EMP-osakkeiden muunto B-sarjan osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bb9a10021ca9e617b1a0dcc2723062db4&lang=fi&src=listed |
| 2025-01-23 10:00:00 | Nightingale Health julkistaa Singaporessa ja Yhdysvalloissa lanseerattavien uuden sukupolven sairastumisriskiennusteidensa suorituskyvyn | https://view.news.eu.nasdaq.com/view?id=bb99694ce9d60545521f5c6013957510a&lang=fi&src=listed |
| 2025-01-23 10:00:00 | Nightingale Health announces the performance metrics of its latest generation disease risk assessments to be rolled out in Singapore and the United States | https://view.news.eu.nasdaq.com/view?id=b3a3b346192eaf2227a0ad42f29f49ded&lang=en&src=listed |
| 2025-01-27 08:00:00 | Nightingale Health ja Enigma Genomics aloittavat yhteistyön Nightingale Remote Health Check -palvelun myymiseksi MENA-alueella | https://view.news.eu.nasdaq.com/view?id=b380c7ef199343f0357503c1a550ec333&lang=fi&src=listed |
| 2025-01-27 08:00:00 | Nightingale Health and Enigma Genomics enter into collaboration to sell the Nightingale Remote Health Check in the MENA region | https://view.news.eu.nasdaq.com/view?id=ba72631f9f59cea23c30bac333915894f&lang=en&src=listed |
| 2025-02-07 13:15:00 | Nightingale Health julkistaa päivitetyn regulaatiosuunnitelmansa Yhdysvalloissa | https://view.news.eu.nasdaq.com/view?id=bc644125f1ec9d0df1ee2095efe753dd5&lang=fi&src=listed |
| 2025-02-07 13:15:00 | Nightingale Health announces its updated regulatory plan in the United States | https://view.news.eu.nasdaq.com/view?id=b210d399782ff4b3511d2f8858091c698&lang=en&src=listed |
| 2025-02-27 13:15:00 | Nightingale Health kehittää LLM-pohjaisen työkalun joka auttaa tekemään tietoisia terveyspäätöksiä ja vähentämään sairastumisriskejä | https://view.news.eu.nasdaq.com/view?id=b70a64602854fed321093d516e9b5c16b&lang=fi&src=listed |
| 2025-02-27 13:15:00 | Nightingale Health announces the development of innovative LLM based tool to empower anyone to take informed decisions to lower disease risks | https://view.news.eu.nasdaq.com/view?id=bf0c4ffde73271f4bbd87a261b156d645&lang=en&src=listed |
| 2025-02-28 11:35:00 | Nightingale Health to publish half-year report for July - December 2024 on 6 March 2025 | https://view.news.eu.nasdaq.com/view?id=b059b84a44aa6698be806b6f96e75612e&lang=en&src=listed |
| 2025-02-28 11:35:00 | Nightingale Health julkaisee 6.3.2025 puolivuotiskatsauksen heinä-joulukuulta 2024 | https://view.news.eu.nasdaq.com/view?id=b029c104953476c2ab1499937714b28f7&lang=fi&src=listed |
| 2025-03-06 08:00:00 | Nightingale Healthin puolivuotiskatsaus: Kansainvälinen laajentuminen jatkuu Kaakkois-Aasiassa ja Yhdysvalloissa | https://view.news.eu.nasdaq.com/view?id=b249a5ecb8d086d6438eceae70a08cd7a&lang=fi&src=listed |
| 2025-03-06 08:00:00 | Nightingale Health's half-year report: International expansion continues in Southeast Asia and the United States | https://view.news.eu.nasdaq.com/view?id=b43a031ddd7c66e99203617d078b30242&lang=en&src=listed |
| 2025-03-12 13:30:00 | Nightingale Health Oyj hakee B-sarjan osakkeensa listausta Nasdaq Helsingin päälistalle | https://view.news.eu.nasdaq.com/view?id=ba2257b7b132bfc2ce3f4a0e73b9745ec&lang=fi&src=listed |
| 2025-03-12 13:30:00 | Nightingale Health Plc applies for its series B shares to be listed on the Main Market of Nasdaq Helsinki | https://view.news.eu.nasdaq.com/view?id=bcee8a66fbaae1815992342436ca34b53&lang=en&src=listed |
| 2025-03-17 12:55:00 | Nightingale Health establishes ADR program in the US - trading in Company's B shares and ADRs begins on 19 March 2025 at the earliest and 24 March 2025 at the latest on the OTCQX Market in the US | https://view.news.eu.nasdaq.com/view?id=b9c0f5c10882de8e001a014c551d81a73&lang=en&src=listed |
| 2025-03-17 12:55:00 | Nightingale Health on perustanut ADR-ohjelman Yhdysvaltoihin - kaupankäynti Yhtiön B-osakkeilla ja ADR:illä alkaa aikaisintaan 19.3.2025 ja viimeistään 24.3.2025 OTCQX-markkinapaikalla Yhdysvalloissa | https://view.news.eu.nasdaq.com/view?id=b730e77f36e5078b5bcc397c9e5a033a1&lang=fi&src=listed |
| 2025-03-17 15:15:00 | Finanssivalvonta on hyväksynyt Nightingale Health Oyj:n suomenkielisen listalleottoesitteen | https://view.news.eu.nasdaq.com/view?id=b837fe9c7fec938d78df4e5fae3be0c4b&lang=fi&src=listed |
| 2025-03-17 15:15:00 | The Finnish Financial Supervisory Authority has approved Nightingale Health Plc's Finnish prospectus | https://view.news.eu.nasdaq.com/view?id=bc6e1bc31eefcd18dfe614de24ed8295c&lang=en&src=listed |
| 2025-03-18 10:30:00 | Nightingale Health Plc's listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 2025 | https://view.news.eu.nasdaq.com/view?id=b6f2b79f420cd2d80c2328ee6f5400814&lang=en&src=listed |
| 2025-03-18 10:30:00 | Nightingale Health Oyj:n listalleottohakemus on hyväksytty ja kaupankäynti yhtiön B-sarjan osakkeilla alkaa Nasdaq Helsingin päälistalla 19.3.2025 | https://view.news.eu.nasdaq.com/view?id=b9ff93f0354bf150183a8b3a4158f5eed&lang=fi&src=listed |
| 2025-03-21 12:00:00 | Kaupankäynti Nightingale Healthin B-osakkeilla ja ADR:illä alkaa 21.3.2025 OTCQX International -markkinapaikalla Yhdysvalloissa | https://view.news.eu.nasdaq.com/view?id=b458721ba17dbce0315bfc4441aae7839&lang=fi&src=listed |
| 2025-03-21 12:00:00 | Trading in Nightingale Health's B shares and ADRs begins on 21 March 2025 on the OTCQX International Market in the US | https://view.news.eu.nasdaq.com/view?id=b90e30b1c75888d22ca89375b9a4cfd0b&lang=en&src=listed |
| 2025-04-10 08:30:00 | Nightingale Health's laboratory implementation in the United States progresses as planned - opens first to medical research customers in Summer 2025 | https://view.news.eu.nasdaq.com/view?id=b4a3bf7040e30e9b99e08ceb6cc4e6b72&lang=en&src=listed |
| 2025-04-23 17:15:00 | Conversion of Nightingale Health Plc's Series A shares to Series B shares | https://view.news.eu.nasdaq.com/view?id=b6fdb67c59b5a7abc627507eeda0057c8&lang=en&src=listed |
| 2025-05-02 15:45:00 | Changes in Nightingale Health Plc's Management Team | https://view.news.eu.nasdaq.com/view?id=b7d22a71b11c8f2e3a19547914ced7972&lang=en&src=listed |
| 2025-06-09 15:15:00 | Nightingale Health's Board of Directors resolved on new stock option program | https://view.news.eu.nasdaq.com/view?id=b0e3425f99142117fb8ea7857fd141b31&lang=en&src=listed |
| 2025-06-12 15:15:00 | Nightingale Health's management team members Minja Salmio and Satu Saksman recognized for outstanding leadership | https://view.news.eu.nasdaq.com/view?id=b8f5c30658d8cedd27d30b22add75449e&lang=en&src=listed |
| 2025-06-13 10:50:00 | Nightingale Health strengthens its commercial operations with new EMEA appointment | https://view.news.eu.nasdaq.com/view?id=b46b3a03895ac9218f0b4cd825f256980&lang=en&src=listed |
| 2025-06-16 08:35:00 | Globally unique preventative healthcare initiative to be launched in Finland: public healthcare to apply Nightingale Health's disease risk detection technology | https://view.news.eu.nasdaq.com/view?id=b52e8d212b430cb8cefd81899d487691a&lang=en&src=listed |
| 2025-06-30 16:15:00 | Nightingale Health's U.S. laboratory now open | https://view.news.eu.nasdaq.com/view?id=bdd6693818e9d48caa33427a164a362bf&lang=en&src=listed |
| 2025-07-02 11:55:00 | Inside information profit warning: Nightingale Health's revenue increases and adjusted EBITDA declines compared to the previous financial year | https://view.news.eu.nasdaq.com/view?id=bbc9abee40565f78994a9d3f590daa898&lang=en&src=listed |
| 2025-07-07 07:00:00 | Nightingale Health selected as provider for landmark Italian population study | https://view.news.eu.nasdaq.com/view?id=b97fe5554bbb414787c6d942c7c1123c8&lang=en&src=listed |
| 2025-09-08 15:10:00 | Conversion of Nightingale Health Plc's EMP shares to Series B shares | https://view.news.eu.nasdaq.com/view?id=b83a8bbeb5a263fc68ba3bf656456a444&lang=en&src=listed |
| 2025-09-16 09:25:00 | Inside information: Nightingale Health selected as multiomics provider for EUR 2.4 million research project | https://view.news.eu.nasdaq.com/view?id=b7418454b911ae94240785810868c720e&lang=en&src=listed |
| 2025-09-18 08:00:00 | Nightingale Health Plc Financial Statements Release 1 July 2024 - 30 June 2025 | https://view.news.eu.nasdaq.com/view?id=b0556466e9afe19afe384d939d0dadf35&lang=en&src=listed |
| 2025-09-25 11:10:00 | Breakthrough in cardiovascular disease risk assessment - Nightingale Health to offer Lp(a) risk detection as part of its routine health check | https://view.news.eu.nasdaq.com/view?id=b50df4d206a2c511878ed0c68e51ad9e6&lang=en&src=listed |
| 2025-10-02 08:00:00 | Nightingale Health's Annual Report for financial year 2024-2025 has been published | https://view.news.eu.nasdaq.com/view?id=bba359ccfd3c7baa87be36df35102ad3a&lang=en&src=listed |
| 2025-10-02 14:30:00 | Notice to the Annual General Meeting of Nightingale Health Plc | https://view.news.eu.nasdaq.com/view?id=b73195411e15c80e0a24d0e2fe8f4b8ef&lang=en&src=listed |
| 2025-11-05 11:50:00 | Nightingale Health partners with Alamar Biosciences to expand its unique multiomics offering with ultra-sensitive proteomics for brain health | https://view.news.eu.nasdaq.com/view?id=bb27b706fe599fb6f82656897da113e36&lang=en&src=listed |
| 2025-11-06 16:10:00 | Resolutions of the Annual General Meeting and the Board of Directors' organizational meeting of Nightingale Health Plc | https://view.news.eu.nasdaq.com/view?id=b66f23bfbc4a3a920709ba8e2ca1466d1&lang=en&src=listed |
| 2025-11-20 09:00:00 | Nightingale Health enables access to world's largest metabolomics dataset through UK Biobank collaboration | https://view.news.eu.nasdaq.com/view?id=b8b2e097ce20ce85262dcf21768c2d7e7&lang=en&src=listed |
| 2025-11-26 10:00:00 | Terveystalo and Nightingale Health deepen strategic partnership - preventive healthcare available to all Terveystalo customers in Finland | https://view.news.eu.nasdaq.com/view?id=b2cb93e79389edda4efd303e00b0cfe1b&lang=en&src=listed |
| 2025-12-08 09:35:00 | Change in Nightingale Health Plc's Management Team | https://view.news.eu.nasdaq.com/view?id=b4aa1e63cd00692d5991521901684f26e&lang=en&src=listed |
| 2025-12-12 13:55:00 | Nightingale Health Plc restructures Management Team to accelerate healthcare business growth | https://view.news.eu.nasdaq.com/view?id=b5a988e92272ded04f560d6474b15ab9f&lang=en&src=listed |
| 2025-12-17 08:30:00 | Landmark study: Nightingale Health's blood test can improve prevention of heart attacks and strokes by 44% compared to current clinical practice | https://view.news.eu.nasdaq.com/view?id=b9307e55de6ed601e75bdfef21b4b053e&lang=en&src=listed |
| 2025-12-18 14:00:00 | North Karelia Wellbeing Services County adopts Nightingale Health's disease risk assessment as part of public healthcare in Finland | https://view.news.eu.nasdaq.com/view?id=b7d19bdd2544ec6d505029fcee9c58e34&lang=en&src=listed |
| 2026-02-09 20:30:00 | Inside information: Nightingale Health achieves major milestone in the United States: New York laboratory now holds a clinical laboratory permit from New York State | https://view.news.eu.nasdaq.com/view?id=b08e6dc438ff4121c93abc508332608fb&lang=en&src=listed |
| 2026-03-05 08:00:00 | Nightingale Health's half-year report: Delivering clinical value for healthcare and moving toward 50% revenue growth supported by a strong sales pipeline | https://view.news.eu.nasdaq.com/view?id=b2ac765c6bbc7d449ad4817e242e9875a&lang=en&src=listed |
| 2026-05-18 12:02:00 | Nightingale Health Plc: Flagging notification in accordance with Chapter 9 Section 10 of the Securities Markets Act (Cor Group Oy) | https://view.news.eu.nasdaq.com/view?id=b290aec2b8182281ab775c9df4b861ea0&lang=en&src=listed |
| 2026-05-27 15:45:00 | Nightingale Health Plc's financial reporting and Annual General Meeting in financial year 2026-2027 | https://view.news.eu.nasdaq.com/view?id=bd1e74da5d845111159533aca2c0cd144&lang=en&src=listed |
| 2026-06-08 18:25:00 | Inside information profit warning: Nightingale Health continues to grow but will not reach its 50% growth target this financial year as about EUR 2 million of revenue shifts to next financial year | https://view.news.eu.nasdaq.com/view?id=b5fc28662bd1ad6d30f522395867bdb47&lang=en&src=listed |
| 2026-06-29 17:15:00 | Nightingale Health's Board of Directors resolved on new stock option program | https://view.news.eu.nasdaq.com/view?id=b5e4bc186d998e27fddd7e85e6eeaf7da&lang=en&src=listed |
